Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response

Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response

US Patent 12268739 · Granted Apr 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Allosteric EGFR inhibitors and methods of use thereof2025
Allosteric EGFR inhibitors and methods of use thereof2025
Small-molecule focal adhesion kinase (FAK) inhibitors2025
Multi-cable interconnect connection system2025
Degraders of WEE1 kinase2025
Inhibitors of EGFR and methods of use thereof2024
Cable pillar for director switch systems2024
Dual connect switch module2024
Antigen binding molecules targeting SARS-CoV-22024
Inhibitors of EGFR and/or HER2 and methods of use2024
PVRIG polypeptides and methods of treatment2023
Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for2023